Clinical trials
Phase 1 Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 5 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Recruiting | 7 |
| Unknown status | 6 |
| Terminated | 5 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 19 |
| AstraZeneca | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Bristol-Myers Squibb | 3 |
| MedImmune LLC | 3 |
| Washington University School of Medicine | 3 |
| Peking Union Medical College Hospital | 2 |
| Abbott Products | 1 |
| AtheroNova Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 74 |
| Cardiovascular Diseases | 11 |
| Inflammation | 9 |
| Hypercholesterolemia | 7 |
| Peripheral Arterial Disease | 7 |
| Coronary Artery Disease | 4 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Acute Coronary Syndrome | 3 |
| Hypertension | 3 |
Trials
Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.